Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
0.3660
+0.0412
+(12.68%)
At close: February 28 at 3:29:01 PM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-13,563
-12,034
-11,730
-11,985
-7,662
Investing Cash Flow
-1,507
-4,041
-8,269
-32,248
-19,072
Financing Cash Flow
13,151
7,330
23,014
30,637
47,887
End Cash Position
-702
2,006
10,751
7,736
21,332
Capital Expenditure
--
-4,041
-8,269
-32,403
-18,750
Issuance of Capital Stock
5,600
5,600
31,227
21,463
53,875
Issuance of Debt
--
6,214
5,068
10,175
--
Repayment of Debt
--
-3,215
-7,538
-148
-1,504
Free Cash Flow
-14,585
-16,075
-19,999
-44,388
-26,412
12/31/2020 - 5/6/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
EVT.BE Evotec SE
8.27
-0.66%
EVT.VI Evotec SE
8.23
-3.58%
TKD.SG Takeda Pharmaceutical Co Ltd
27.50
+1.55%
N4P.L N4 Pharma Plc
0.5250
0.00%
TKUN.TA Tikun Olam-Cannbit Pharmaceuticals Ltd
35.30
-6.12%
PLCN.CN Cannibble Food-Tech Ltd.
0.0200
0.00%
SBX.DE SynBiotic SE
3.6500
+1.11%
INCR.TA InterCure Ltd.
560.00
-1.69%
DICOT.ST Dicot Pharma AB
0.2745
-4.85%
MYCO.CN Mydecine Innovations Group Inc.
0.0050
0.00%